Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani (Q56749822)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559811%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

title

Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559811%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Leishmania donovani

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559811%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Rentala Madhubala

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559811%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

author name string

Bindu Sukumaran

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559811%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Poonam Tewary

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559811%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

language of work or name

English

0 references

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559811%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559811%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559811%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

issue

11-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559811%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

page(s)

1292-1299

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559811%20AND%20SRC:MED&resulttype=core&format=json

Designer vaccines for parasitic diseases

17 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Protection against Leishmania major challenge infection in mice vaccinated with live recombinant parasites expressing a cytotoxic gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Vaccination of BALB/c mice with Leishmania major amastigote-specific cysteine proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Increased expression of LD1 genes transcribed by RNA polymerase I in Leishmania donovani as a result of duplication into the rRNA gene locus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

A DNA sequence (LD1) which occurs in several genomic organizations in Leishmania

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Exposing the immunology of naked DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Leishmania donovani: Characterization and Expression of ORFF, a Gene Amplified from the LDI Locus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

The Leishmania donovani LD1 locus gene ORFG encodes a biopterin transporter (BT1).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

A frequently amplified region in Leishmania contains a gene conserved in prokaryotes and eukaryotes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

A multicopy, extrachromosomal DNA in Leishmania infantum contains two inverted repeats of the 27.5-kilobase LD1 sequence and encodes numerous transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Immunization with recombinant LD1 antigens protects against experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

DNA vaccines: technology and application as anti-parasite and anti-microbial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

1 reference

7 January 2021

Clinical spectrum of Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900352-3

7 January 2021

10.1016/S0264-410X(02)00352-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559811%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference